Sofosbuvir + Ledipasvir
Paul G. Auwaerter, M.D., Janessa Smith M. Smith, PharmD, BCPS
INDICATIONS
INDICATIONS
INDICATIONS
FDA
FDA
- Treatment of chronic hepatitis C virus (HCV) genotypes 1, 4, 5 or 6 infections without cirrhosis or with compensated cirrhosis.
- Also, genotype 1 with decompensated cirrhosis in combination with ribavirin.
- Genotype 1 or 4 in liver transplant recipients without cirrhosis or with compensated cirrhosis with ribavirin.
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2025 Unbound Medicine, Inc. All rights reserved